3
Announcements
Trials
Browse
Landscape
Status
Unknown
3
Completed
3
Recruiting
2
Active not recruiting
2
Terminated
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Gastrointestinal
52
Thoracic
33
Breast
33
Genitourinary
25
Gynecologic
24
CNS
19
Tumor-Agnostic
17
Head & Neck
17
Lymphoid
16
Sarcoma
13
Other hematologic neoplasm
11
Dermatologic
10
Myeloid
6
Plasma cell
5
Other solid neoplasm
3
Endocrine
2
NET
1
Classical hematology
1
Conditions
Pheochromocytoma
1
Paraganglioma
1
Neuroendocrine Tumors
1
Interventions
lutetium Lu 177 dotatate
16
Magnetic Resonance Spectroscopy
14
gallium Ga 68 dotatate
9
Specimen Handling
8
Everolimus
8
pembrolizumab
7
cabozantinib
6
Cisplatin
6
fluorodopa F 18
5
Etoposide
5
trametinib
4
surufatinib
4
lanreotide
4
dabrafenib
4
cemiplimab
4
X-Rays
4
Temozolomide
4
Nivolumab
4
Lutetium-177
4
Lutetium
4
Fluorodeoxyglucose F18
4
Carboplatin
4
177Lu-octreotide, DOTA(0)-Tyr(3)-
4
olaparib
3
lenvatinib
3
copper dotatate CU-64
3
Transurethral Resection of Prostate
3
Thyrotropin Alfa
3
Surveys and Questionnaires
3
Somatostatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Blood Specimen Collection
×
Endocrine
×
Clear all
NCT06430021
2026-05-22
PRO-NEM1
Centre Hospitalier Universitaire Dijon
Recruiting
297 enrolled
NCT06444607
2024-11-21
HEPHESTOS
Radboud University Medical Center
Recruiting
200 enrolled